Cargando…

Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease

RATIONALE & OBJECTIVE: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Data from adults and children with proteinu...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Donald J., Waldo, Anne, Oh, Gia J., Kamil, Elaine S., Elliott, Matthew, Adler, Sharon, Pesenson, Anne, Modes, Meg M., Gipson, Patrick, Lafayette, Richard A., Selewski, David T., Attalla, Samara E., Eikstadt, Richard, Troost, Jonathan P., Gipson, Debbie S., Massengill, Susan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380443/
https://www.ncbi.nlm.nih.gov/pubmed/32734234
http://dx.doi.org/10.1016/j.xkme.2019.10.012
_version_ 1783562856616165376
author Weaver, Donald J.
Waldo, Anne
Oh, Gia J.
Kamil, Elaine S.
Elliott, Matthew
Adler, Sharon
Pesenson, Anne
Modes, Meg M.
Gipson, Patrick
Lafayette, Richard A.
Selewski, David T.
Attalla, Samara E.
Eikstadt, Richard
Troost, Jonathan P.
Gipson, Debbie S.
Massengill, Susan F.
author_facet Weaver, Donald J.
Waldo, Anne
Oh, Gia J.
Kamil, Elaine S.
Elliott, Matthew
Adler, Sharon
Pesenson, Anne
Modes, Meg M.
Gipson, Patrick
Lafayette, Richard A.
Selewski, David T.
Attalla, Samara E.
Eikstadt, Richard
Troost, Jonathan P.
Gipson, Debbie S.
Massengill, Susan F.
author_sort Weaver, Donald J.
collection PubMed
description RATIONALE & OBJECTIVE: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study. EXPOSURE: Proteinuric kidney disease. OUTCOMES: Hypertension and BP control. ANALYTICAL APPROACH: Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensive therapy excluding renin-angiotensin-aldosterone system blockade. Elevated BP was defined as greater than 95th percentile for children and >140/90 mm Hg in adults. Sustained BP control was defined as 2 or more consecutive encounters with BPs lower than 95th percentile for children and <140/90 mm Hg for adults. Kaplan-Meier and Cox proportional hazards analyses were used to evaluate the time to initiation of antihypertensive therapy. RESULTS: 842 patients, 69% adults and 31% children, with a total observation period of 6,722 patient-years were included in the analysis. 644 (76%) had hypertension during observation. There was no difference in the prevalence of hypertension between children and adults (74% vs 78%; P = 0.3). Hypertension was most common among those of African American race compared with other races (90% vs 72%-75%; P = 0.003). 504 (78%) patients with hypertension achieved BP control but only 51% achieved control within 1 year. 140 (22%) patients with hypertension never achieved BP control during a median of 41 (IQR, 24-73) months of observation. LIMITATIONS: Differing BP control goals that may lead to overestimation of the controlled patient population. CONCLUSIONS: Hypertension affects most patients with proteinuric kidney disease regardless of age. Time to BP control exceeded 1 year in 50% of patients with hypertension and 22% did not demonstrate control. This study highlights the need to address hypertension early and completely in disease management of patients with proteinuric kidney disease.
format Online
Article
Text
id pubmed-7380443
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73804432020-07-29 Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease Weaver, Donald J. Waldo, Anne Oh, Gia J. Kamil, Elaine S. Elliott, Matthew Adler, Sharon Pesenson, Anne Modes, Meg M. Gipson, Patrick Lafayette, Richard A. Selewski, David T. Attalla, Samara E. Eikstadt, Richard Troost, Jonathan P. Gipson, Debbie S. Massengill, Susan F. Kidney Med Original Research RATIONALE & OBJECTIVE: The objective of the study was to estimate the prevalence of hypertension in patients with proteinuric kidney disease and evaluate blood pressure (BP) control. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Data from adults and children with proteinuric kidney disease enrolled in the multicenter Kidney Research Network Registry were used for this study. EXPOSURE: Proteinuric kidney disease. OUTCOMES: Hypertension and BP control. ANALYTICAL APPROACH: Patients with white-coat hypertension were excluded. Patients were censored at end-stage kidney disease onset. Patients were defined as hypertensive either by hypertension diagnosis code, having 2 or more encounters with elevated BPs, or treatment with antihypertensive therapy excluding renin-angiotensin-aldosterone system blockade. Elevated BP was defined as greater than 95th percentile for children and >140/90 mm Hg in adults. Sustained BP control was defined as 2 or more consecutive encounters with BPs lower than 95th percentile for children and <140/90 mm Hg for adults. Kaplan-Meier and Cox proportional hazards analyses were used to evaluate the time to initiation of antihypertensive therapy. RESULTS: 842 patients, 69% adults and 31% children, with a total observation period of 6,722 patient-years were included in the analysis. 644 (76%) had hypertension during observation. There was no difference in the prevalence of hypertension between children and adults (74% vs 78%; P = 0.3). Hypertension was most common among those of African American race compared with other races (90% vs 72%-75%; P = 0.003). 504 (78%) patients with hypertension achieved BP control but only 51% achieved control within 1 year. 140 (22%) patients with hypertension never achieved BP control during a median of 41 (IQR, 24-73) months of observation. LIMITATIONS: Differing BP control goals that may lead to overestimation of the controlled patient population. CONCLUSIONS: Hypertension affects most patients with proteinuric kidney disease regardless of age. Time to BP control exceeded 1 year in 50% of patients with hypertension and 22% did not demonstrate control. This study highlights the need to address hypertension early and completely in disease management of patients with proteinuric kidney disease. Elsevier 2020-01-17 /pmc/articles/PMC7380443/ /pubmed/32734234 http://dx.doi.org/10.1016/j.xkme.2019.10.012 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Weaver, Donald J.
Waldo, Anne
Oh, Gia J.
Kamil, Elaine S.
Elliott, Matthew
Adler, Sharon
Pesenson, Anne
Modes, Meg M.
Gipson, Patrick
Lafayette, Richard A.
Selewski, David T.
Attalla, Samara E.
Eikstadt, Richard
Troost, Jonathan P.
Gipson, Debbie S.
Massengill, Susan F.
Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_full Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_fullStr Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_full_unstemmed Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_short Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
title_sort time to initiation of antihypertensive therapy after onset of elevated blood pressure in patients with primary proteinuric kidney disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380443/
https://www.ncbi.nlm.nih.gov/pubmed/32734234
http://dx.doi.org/10.1016/j.xkme.2019.10.012
work_keys_str_mv AT weaverdonaldj timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT waldoanne timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT ohgiaj timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT kamilelaines timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT elliottmatthew timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT adlersharon timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT pesensonanne timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT modesmegm timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT gipsonpatrick timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT lafayettericharda timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT selewskidavidt timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT attallasamarae timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT eikstadtrichard timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT troostjonathanp timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT gipsondebbies timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease
AT massengillsusanf timetoinitiationofantihypertensivetherapyafteronsetofelevatedbloodpressureinpatientswithprimaryproteinurickidneydisease